The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Sierra Leone currently stands at 69%, indicating a decrease of 24% (-25.8%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Sierra Leone
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Sierra Leone
PMTCT antiretroviral therapy coverage
More indicators for Sierra Leone
Male unintentional poisoning
3.3
-0.1
(2019)
Female wasting in children
5.7%
+0.5%
(2021)
Female prevalence of HIV
1%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar78
-intl dollar4
(2021)
Birth registration
90.4%
+9.3%
(2019)
Contraceptive modern method prevalence
20.9%
-1%
(2019)
Sierra Leone PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 69% | -24% |
| 2021 | 93% | +31% |
| 2020 | 62% | -5% |
| 2019 | 67% | -6% |
| 2018 | 73% | +7% |
| 2017 | 66% | +6% |
| 2016 | 60% | +1% |
| 2015 | 59% | +10% |
| 2014 | 49% | -3% |
| 2013 | 52% | -7% |
| 2012 | 59% | +13% |
| 2011 | 46% | +11% |
| 2010 | 35% | +10% |
| 2009 | 25% | -4% |
| 2008 | 29% | +20% |
| 2007 | 9% | +3% |
| 2006 | 6% | +5% |
| 2005 | 1% | +1% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |